A
AREV
vs
S
S&P TSX Composite Index (Canada)
Over the past 12 months, AREV has underperformed S&P TSX Composite Index (Canada), delivering a return of 0% compared to the S&P TSX Composite Index (Canada)'s +41% growth.
Stocks Performance
AREV vs S&P TSX Composite Index (Canada)
Performance Gap
AREV vs S&P TSX Composite Index (Canada)
Performance By Year
AREV vs S&P TSX Composite Index (Canada)
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
AREV Life Sciences Global Corp
Glance View
AREV Life Sciences Global Corp. engages in the production and development of natural health and cannabis infused products. The company is headquartered in Coquitlam, British Columbia. The company went IPO on 2007-07-12. The firm focuses on delivering solutions to public healthcare metrics through collaborations in the life science industry. Its initial business is to produce and sell functional ingredients produced through its extraction systems. These ingredients and products are targeted at the natural health, medical, functional food, nutraceutical, sport nutrition markets. Its technologies enable the extraction of targeted essential and functional oils from target biomass, including hemp, create formulations combining cannabidiol (CBD) with these extracted oils or powders offered in various delivery methods, such as gel caps in branded formats for consumer markets. The company offers nutraceutical products, ready to use therapeutic food products (RUTF's) and therapeutic drug discovery. Its subsidiaries include AREV (Cambodia) Brands Co., Ltd. and AREV Life Sciences Inc.
